Joint Formulary & PAD

Beclometasone with formoterol (Fostair) - Asthma

You are here : Home > Formulary Search > Beclometasone with formoterol (Fostair) - Asthma

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Inhaler (Metered Dose)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
R
SPC
Restrictions / Comments :

Documentation

Webpage
How to use a metered dose inhaler (MDI) with a large volume spacer - video
Webpage
How to use a metered dose inhaler (MDI) with a small volume spacer - video
Webpage
NICE NG80 - Asthma-diagnosis-monitoring-and-chronic-asthma-management
Patient resource
MART Fostair Nexthaler and MDI Asthma Action plan - July 2019
Patient resource
How to use a metered dose inhaler (MDI) with a small volume spacer - Patient information leaflet
Patient resource
How to use a metered dose inhaler (MDI) - Patient information leaflet
Patient resource
How to use a metered dose inhaler (MDI) - video
Patient resource
How to use a metered dose inhaler (MDI) with a large volume spacer - Patient information leaflet
Information
Review of Fostair Traffic Light Status for APC - Aug 2025

PAD Profile

ChemicalSubstance :
Beclometasone with formoterol (Fostair)
Indication :
Asthma
Group Name :
ICS LABA
Keywords :
ICS LABAs, ICS/LABAs, inhaled corticosteroids, long-acting beta agonists, respiratory, asthmatics, MART action plans, maintenance and reliever therapy
Brand Names Include :
Fostair
Important Information :

In new patients - Only for those who have had a trial of Proxor and where the specialist team consider that a trial of Fostair pMDI would be beneficial.

Proxor device is the preferred beclometasone with formoterol pMDI.

Fostair 100/6, 200/6 not licensed in under 18 years. Not licensed for AIR.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Asthma
Supporting Documents :
9

Committee Recommendations (1)

01 Oct 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee agreed a change in traffic light status from NON-FORMULARY to BLUE (on specialist recommendation) for Fostair pMDI

ONLY in those patients who have had a trial of Proxor, and the specialist team consider would benefit from a trial of Fostair pMDI.

The APC members agreed that this decision will be reviewed in 12 months when there has been wider clinical experience in the use of Proxor.

Further information can be ofund in the document titled: "Review of Fostair Traffic Light Status for APC".

Other Indications

Below are listed other indications that Beclometasone with formoterol (Fostair) is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Asthma.